NDDPX 08Alternative Names: Bromocriptine - Neugen Pharma KK; NDDPX08
Latest Information Update: 23 Dec 2010
At a glance
- Originator Neugen Pharma
- Class Antihyperglycaemics; Antiparkinsonians; Ergolines; Ergotamines; Infertility therapies
- Mechanism of Action Dopamine D2 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Clinical Phase Unknown Amyotrophic lateral sclerosis